122 related articles for article (PubMed ID: 2165822)
1. [Interaction of calcium agonists and antagonists with Ca-binding proteins and their effect on cyclic nucleotide phosphodiesterase].
Feoktistov IA; Baldenkov GN; Barannik IV; Cherviakov EB; Larionov NP
Biokhimiia; 1990 Apr; 55(4):754-9. PubMed ID: 2165822
[TBL] [Abstract][Full Text] [Related]
2. [Effect of troponin I on the Ca-binding properties of calmodulin and activation of cyclic nucleotide phosphodiesterase by Ca ions].
Men'shikov MIu; Rybin VO; Tkachuk VA
Dokl Akad Nauk SSSR; 1981; 258(5):1250-4. PubMed ID: 6266797
[No Abstract] [Full Text] [Related]
3. Calmodulin antagonistic action of KS-504a, a novel metabolite of the fungus Mollisia ventosa.
Nakanishi S; Kuroda K; Osawa K; Kase H
Agric Biol Chem; 1990 Oct; 54(10):2697-702. PubMed ID: 1369297
[TBL] [Abstract][Full Text] [Related]
4. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
5. Identical inhibitory modulation of A-type potassium currents by dihydropyridine calcium channel agonists and antagonists.
Mlinar B; Enyeart JJ
Mol Pharmacol; 1994 Oct; 46(4):743-9. PubMed ID: 7969054
[TBL] [Abstract][Full Text] [Related]
6. Effects of ruthenium red on activation of Ca2(+)-dependent cyclic nucleotide phosphodiesterase.
Masuoka H; Ito M; Nakano T; Naka M; Tanaka T
Biochem Biophys Res Commun; 1990 May; 169(1):315-22. PubMed ID: 1693502
[TBL] [Abstract][Full Text] [Related]
7. The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.
Thayer SA; Fairhurst AS
Mol Pharmacol; 1983 Jul; 24(1):6-9. PubMed ID: 6865927
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
Tanaka M; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
[TBL] [Abstract][Full Text] [Related]
9. [Effect of pH on Ca-binding properties of calmodulin and on its interaction with Ca-dependent phosphodiesterase of cyclic nucleotides].
Tkachuk VA; Men'shikov MIu
Biokhimiia; 1981 Jun; 46(6):963-73. PubMed ID: 6266519
[TBL] [Abstract][Full Text] [Related]
10. [Effect of neurotropic drugs on calmodulin and troponin C-dependent processes].
Baldenkov GN; Men'shikov MIu; Feoktistov IA; Tkachuk VA
Biokhimiia; 1985 Jul; 50(7):1141-50. PubMed ID: 2864085
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of cyclic nucleotide phosphodiesterase and calmodulin in the small intestinal mucosa of rabbits].
Iurkov VA
Biull Eksp Biol Med; 1981 Jul; 92(7):91-4. PubMed ID: 6271290
[TBL] [Abstract][Full Text] [Related]
12. A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors.
Gietzen K; Sadorf I; Bader H
Biochem J; 1982 Dec; 207(3):541-8. PubMed ID: 6299272
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine.
Sugden MC; Ashcroft SJ
Biochem J; 1981 Aug; 197(2):459-64. PubMed ID: 6275834
[TBL] [Abstract][Full Text] [Related]
14. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
Drees M; Zimmermann R; Eisenbrand G
Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
[TBL] [Abstract][Full Text] [Related]
15. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists.
Sharma RK; Wang JH; Wu Z
J Neurochem; 1997 Aug; 69(2):845-50. PubMed ID: 9231746
[TBL] [Abstract][Full Text] [Related]
18. [Use of 3,3'-dipropylthiodicarbocyanine iodide diS-C3-(5) for the study of conformational changes and detection of Ca-binding proteins].
Orlov SN; Pokudin NI; Riazhskiĭ GG; Kravtsov GM
Biokhimiia; 1984 Jan; 49(1):51-9. PubMed ID: 6322870
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes.
Bartel S; Vetter D; Schlegel WP; Wallukat G; Krause EG; Karczewski P
J Mol Cell Cardiol; 2000 Dec; 32(12):2173-85. PubMed ID: 11112993
[TBL] [Abstract][Full Text] [Related]
20. [Effect of lipids on the binding of calmodulin with cyclic nucleotide phosphodiesterase].
Severin SE; Shvets VI; Tkachuk VA
Biokhimiia; 1983 Aug; 48(8):1337-46. PubMed ID: 6313075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
